GNH USA

Europe — EMA

Meloxicam Cinfa

GNH USA supplies Meloxicam Cinfa (Meloxicam), a non‑steroidal anti‑inflammatory drug for osteoarthritis, rheumatoid arthritis and acute musculoskeletal pain.

Meloxicam

Request sourcing

1
Pack/s

What is Meloxicam?

Meloxicam, the active ingredient in Meloxicam Cinfa, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It is indicated for the management of osteoarthritis, rheumatoid arthritis and acute musculoskeletal pain in adult patients.

GNH USA supplies Meloxicam Cinfa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU market standards and is distributed to healthcare providers across multiple regions.

What is Meloxicam used for?

Meloxicam acts on inflammatory pathways associated with arthritis and musculoskeletal disorders.

- Osteoarthritis: reduces joint pain and improves functional mobility. - Rheumatoid arthritis: decreases synovial inflammation and slows joint damage progression. - Acute musculoskeletal pain: provides rapid analgesia and reduces swelling.

What are the side effects of Meloxicam?

Adverse reactions may occur with meloxicam use.

Common Side Effects: - Gastrointestinal discomfort such as dyspepsia or nausea. - Headache. - Dizziness. - Peripheral edema.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular thrombotic events (e.g., myocardial infarction, stroke). - Severe skin reactions including Stevens‑Johnson syndrome. - Renal impairment or acute kidney injury.

What precautions apply to Meloxicam?

Use meloxicam with clinical caution and appropriate monitoring.

- Renal function: assess baseline and monitor during therapy. - Cardiovascular risk: use cautiously in patients with a history of heart disease. - Gastrointestinal ulcer risk: avoid in patients with active peptic ulcer disease. - Pregnancy and lactation: not recommended due to unknown safety profile. - Concomitant NSAIDs or anticoagulants: increased risk of bleeding. - Store at ambient temperature: keep in the original container, protect from moisture and light.

What does Meloxicam interact with?

Meloxicam may interact with several medicines; consider the following.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and renal toxicity. - ACE inhibitors or ARBs: potential reduction in renal function.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance nephrotoxic effects. - Lithium: possible increase in serum lithium concentrations.

Frequently asked questions

What is Meloxicam Cinfa used for?+
Meloxicam Cinfa is a prescription NSAID indicated for the treatment of osteoarthritis, rheumatoid arthritis, and acute musculoskeletal pain. It helps relieve pain, reduce inflammation, and improve joint function in adult patients.
How does meloxicam work?+
Meloxicam works by preferentially inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which lowers the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. This selective inhibition provides anti‑inflammatory benefits while sparing COX‑1 activity to a greater extent.
What is the usual dose of meloxicam?+
The dosage of meloxicam is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Typical adult dosing ranges are established in clinical guidelines, but the exact regimen should be individualized by a healthcare professional.
Is meloxicam safe in pregnancy or breastfeeding?+
Safety of meloxicam during pregnancy and lactation has not been established. Because of potential risks to the fetus or infant, it is generally avoided unless the benefits clearly outweigh the risks and no safer alternative is available.
How do I order Meloxicam Cinfa from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does meloxicam compare with other NSAIDs?+
Meloxicam offers a longer half‑life and a higher selectivity for COX‑2 compared with many traditional NSAIDs such as ibuprofen or naproxen. This may allow once‑daily dosing and potentially lower gastrointestinal risk, though individual response and safety profiles vary.
How should Meloxicam Cinfa be stored?+
Store the product at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and ensure the container is tightly closed to maintain stability.
How is Meloxicam Cinfa administered?+
Meloxicam Cinfa is administered orally, usually as a whole tablet swallowed with water. It should be taken with or without food as directed by the prescriber, and the patient should follow any specific instructions regarding timing or concomitant medications.
What are the most serious risks to watch for while taking meloxicam?+
Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe skin reactions (e.g., Stevens‑Johnson syndrome), and renal impairment. Patients should seek immediate medical attention if they experience symptoms like severe abdominal pain, sudden weakness, rash, or reduced urine output.
Who should not use meloxicam?+
Meloxicam should be avoided in patients with known hypersensitivity to meloxicam or other NSAIDs, active gastrointestinal ulcer disease, severe heart failure, uncontrolled hypertension, advanced renal or hepatic impairment, and in those who are pregnant or breastfeeding unless absolutely necessary.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Meloxicam
Route
Oral Use
Manufacturer
Laboratorios Cinfa S.A.
Origin
EU

Related products